AlphAIAlphAI — Financial news for AI agents
zerohedge.comOCT 302 min read$CL

Beyond The AI Massacre: S&P500 Ex-AI Stocks Head For Best Month Since 2022

The S&P 500 ex-AI stocks are set for a 6% monthly gain, the best since 2022, as consumer staples lead. Colgate-Palmolive and Mondelez International rose after earnings beats. The Nasdaq 100 and S&P 500 fell, with Intel seeing record intraday declines. 78% of S&P 500 companies have beaten EPS estimates so far in 3Q.

Original reporting
zerohedge.com
Published Oct 30, 2026, 3:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 6:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Beyond The AI Massacre: S&P500 Ex-AI Stocks Head For Best Month Since 2022 — source image
Source · zerohedge.com
Decision brief

The 30-second read

$CLBullishMed
01

Why it matters

Earnings beats provide fresh positive catalysts for the two consumer staples names, supporting sector rotation away from AI‑heavy tech.

02

Market read

Consumer staples lead the market's rebound, offering short‑term buying opportunities on earnings beat.

03

What to watch

Potential supply‑chain pressures or input‑cost inflation could curb margins.

Relevance 7/10Novelty 7/10Timing: premarket today

Background

The article recaps a broader ex‑AI rally, highlighting earnings beats from Colgate‑Palmolive and Mondelez as key drivers.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive reported Q3 profit and sales above consensus, driving a 5.5% pre‑market rise.

Expected impact

upward pressure as investors price in stronger earnings

Evidence & confidence

Beat of consensus estimates and guidance lift suggest continued demand for consumer staples.

$MDLZBullishHigh confidence
Context

Mondelez International posted Q3 earnings beat, sending shares up ~7% pre‑market.

Expected impact

upward pressure from earnings beat and volume growth

Evidence & confidence

Beat and solid volume growth indicate resilient consumer demand.

Market effects

Sector

Consumer staples sector gains as ex‑AI stocks rally, potentially lifting related ETFs.

Regional

U.S. equity markets see modest upside driven by consumer earnings.

Global

Limited to U.S. markets; no immediate global macro impact.

Counterpoint

What could challenge this read

If earnings guidance softens in upcoming quarters, the rally may be short‑lived.

Key entities

  • company
    Colgate-Palmolive

    Consumer staples maker reporting earnings beat.

  • company
    Mondelez International

    Snack producer reporting earnings beat.

Read at source← All news

Related articles

NOV 2
$MDLZMed

Mondelēz to acquire Undercover Snacks in expansion of better-for-you portfolio

Mondelēz International will acquire a majority stake in Undercover Snacks, expected to close in Q1 2027. Undercover will operate independently within Mondelēz's North America Ventures unit. The deal expands Mondelēz's healthier snack portfolio, according to CEO Dirk Van de Put. Mondelēz reported a 2.3% revenue increase to $9.97 billion in Q3, with Latin America seeing the fastest growth at 12%.

finance.yahoo.com6 min
NOV 2
$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com2 min
NOV 2
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com2 min
NOV 2
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com1 min
NOV 1
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com2 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com3 min